57.24 USD
-0.06 (-0.1%)
57.3027 USD
+0.06 (+0.11%)
Overall MDLZ gets a fundamental rating of 5 out of 10. We evaluated MDLZ against 87 industry peers in the Food Products industry. While MDLZ has a great profitability rating, there are some minor concerns on its financial health. MDLZ does not seem to be growing, but still is valued expensively.
1. Profitability
1.1 Basic Checks
- In the past year MDLZ was profitable.
- In the past year MDLZ had a positive cash flow from operations.
- In the past 5 years MDLZ has always been profitable.
- Each year in the past 5 years MDLZ had a positive operating cash flow.
1.2 Ratios
- Looking at the Return On Assets, with a value of 4.95%, MDLZ is in the better half of the industry, outperforming 74.71% of the companies in the same industry.
- MDLZ's Return On Equity of 13.49% is amongst the best of the industry. MDLZ outperforms 82.76% of its industry peers.
- MDLZ's Return On Invested Capital of 6.25% is fine compared to the rest of the industry. MDLZ outperforms 67.82% of its industry peers.
- The Average Return On Invested Capital over the past 3 years for MDLZ is significantly below the industry average of 27.80%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 4.95% | ||
| ROE | 13.49% | ||
| ROIC | 6.25% |
ROA(3y)5.83%
ROA(5y)5.83%
ROE(3y)14.91%
ROE(5y)14.57%
ROIC(3y)7.83%
ROIC(5y)7.26%
1.3 Margins
- MDLZ has a Profit Margin of 9.38%. This is amongst the best in the industry. MDLZ outperforms 87.36% of its industry peers.
- In the last couple of years the Profit Margin of MDLZ has declined.
- MDLZ has a better Operating Margin (11.59%) than 79.31% of its industry peers.
- MDLZ's Operating Margin has improved in the last couple of years.
- Looking at the Gross Margin, with a value of 31.05%, MDLZ is in the better half of the industry, outperforming 70.11% of the companies in the same industry.
- In the last couple of years the Gross Margin of MDLZ has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 11.59% | ||
| PM (TTM) | 9.38% | ||
| GM | 31.05% |
OM growth 3Y2.71%
OM growth 5Y2.05%
PM growth 3Y-5.45%
PM growth 5Y-3.59%
GM growth 3Y-0.05%
GM growth 5Y-0.42%
2. Health
2.1 Basic Checks
- With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), MDLZ is creating some value.
- MDLZ has less shares outstanding than it did 1 year ago.
- MDLZ has less shares outstanding than it did 5 years ago.
- The debt/assets ratio for MDLZ has been reduced compared to a year ago.
2.2 Solvency
- MDLZ has an Altman-Z score of 2.28. This is not the best score and indicates that MDLZ is in the grey zone with still only limited risk for bankruptcy at the moment.
- MDLZ has a Altman-Z score of 2.28. This is comparable to the rest of the industry: MDLZ outperforms 48.28% of its industry peers.
- The Debt to FCF ratio of MDLZ is 9.31, which is on the high side as it means it would take MDLZ, 9.31 years of fcf income to pay off all of its debts.
- MDLZ has a Debt to FCF ratio of 9.31. This is in the better half of the industry: MDLZ outperforms 60.92% of its industry peers.
- A Debt/Equity ratio of 0.76 indicates that MDLZ is somewhat dependend on debt financing.
- Looking at the Debt to Equity ratio, with a value of 0.76, MDLZ is in line with its industry, outperforming 40.23% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.76 | ||
| Debt/FCF | 9.31 | ||
| Altman-Z | 2.28 |
ROIC/WACC0.83
WACC7.55%
2.3 Liquidity
- MDLZ has a Current Ratio of 0.61. This is a bad value and indicates that MDLZ is not financially healthy enough and could expect problems in meeting its short term obligations.
- The Current ratio of MDLZ (0.61) is worse than 88.51% of its industry peers.
- MDLZ has a Quick Ratio of 0.61. This is a bad value and indicates that MDLZ is not financially healthy enough and could expect problems in meeting its short term obligations.
- MDLZ has a Quick ratio of 0.37. This is amonst the worse of the industry: MDLZ underperforms 82.76% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.61 | ||
| Quick Ratio | 0.37 |
3. Growth
3.1 Past
- MDLZ shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -21.70%.
- Measured over the past 5 years, MDLZ shows a small growth in Earnings Per Share. The EPS has been growing by 6.91% on average per year.
- The Revenue has been growing slightly by 4.13% in the past year.
- The Revenue has been growing slightly by 7.09% on average over the past years.
EPS 1Y (TTM)-21.7%
EPS 3Y6.45%
EPS 5Y6.91%
EPS Q2Q%-26.26%
Revenue 1Y (TTM)4.13%
Revenue growth 3Y8.26%
Revenue growth 5Y7.09%
Sales Q2Q%5.87%
3.2 Future
- The Earnings Per Share is expected to grow by 3.92% on average over the next years.
- MDLZ is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 3.83% yearly.
EPS Next Y-14.35%
EPS Next 2Y-3.62%
EPS Next 3Y0.47%
EPS Next 5Y3.92%
Revenue Next Year4.85%
Revenue Next 2Y4.33%
Revenue Next 3Y4.1%
Revenue Next 5Y3.83%
3.3 Evolution
- The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
- The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
- With a Price/Earnings ratio of 20.08, MDLZ is valued on the expensive side.
- Compared to the rest of the industry, the Price/Earnings ratio of MDLZ is on the same level as its industry peers.
- The average S&P500 Price/Earnings ratio is at 27.38. MDLZ is valued slightly cheaper when compared to this.
- The Price/Forward Earnings ratio is 17.86, which indicates a rather expensive current valuation of MDLZ.
- Based on the Price/Forward Earnings ratio, MDLZ is valued a bit cheaper than the industry average as 60.92% of the companies are valued more expensively.
- MDLZ is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 24.29, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 20.08 | ||
| Fwd PE | 17.86 |
4.2 Price Multiples
- Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of MDLZ is on the same level as its industry peers.
- Compared to the rest of the industry, the Price/Free Cash Flow ratio of MDLZ is on the same level as its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 32.25 | ||
| EV/EBITDA | 15.99 |
4.3 Compensation for Growth
- The decent profitability rating of MDLZ may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)2.91
EPS Next 2Y-3.62%
EPS Next 3Y0.47%
5. Dividend
5.1 Amount
- With a Yearly Dividend Yield of 3.49%, MDLZ has a reasonable but not impressive dividend return.
- MDLZ's Dividend Yield is a higher than the industry average which is at 2.28.
- MDLZ's Dividend Yield is rather good when compared to the S&P500 average which is at 1.85.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.49% |
5.2 History
- On average, the dividend of MDLZ grows each year by 10.52%, which is quite nice.
- MDLZ has paid a dividend for at least 10 years, which is a reliable track record.
- MDLZ has not decreased its dividend for at least 10 years, so it has a reliable track record of non decreasing dividend.
Dividend Growth(5Y)10.52%
Div Incr Years11
Div Non Decr Years11
5.3 Sustainability
- 69.92% of the earnings are spent on dividend by MDLZ. This is not a sustainable payout ratio.
- MDLZ's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP69.92%
EPS Next 2Y-3.62%
EPS Next 3Y0.47%
57.24
-0.06 (-0.1%)
Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryFood Products
Earnings (Last)10-28 2025-10-28/amc
Earnings (Next)02-03 2026-02-03/amc
Inst Owners89.35%
Inst Owner Change-0.25%
Ins Owners0.15%
Ins Owner Change-0.02%
Market Cap73.86B
Revenue(TTM)37.65B
Net Income(TTM)3.53B
Analysts78.24
Price Target68.83 (20.25%)
Short Float %2.46%
Short Ratio3.02
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.49% |
Yearly Dividend1.76
Dividend Growth(5Y)10.52%
DP69.92%
Div Incr Years11
Div Non Decr Years11
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)2.9%
Min EPS beat(2)0.24%
Max EPS beat(2)5.55%
EPS beat(4)3
Avg EPS beat(4)3.23%
Min EPS beat(4)-3.07%
Max EPS beat(4)10.18%
EPS beat(8)7
Avg EPS beat(8)5.65%
EPS beat(12)11
Avg EPS beat(12)5.57%
EPS beat(16)14
Avg EPS beat(16)5.23%
Revenue beat(2)0
Avg Revenue beat(2)-1.02%
Min Revenue beat(2)-1.64%
Max Revenue beat(2)-0.41%
Revenue beat(4)0
Avg Revenue beat(4)-1.62%
Min Revenue beat(4)-2.33%
Max Revenue beat(4)-0.41%
Revenue beat(8)0
Avg Revenue beat(8)-1.65%
Revenue beat(12)4
Avg Revenue beat(12)-0.26%
Revenue beat(16)7
Avg Revenue beat(16)0.39%
PT rev (1m)-1.78%
PT rev (3m)-8.12%
EPS NQ rev (1m)-0.15%
EPS NQ rev (3m)-15.64%
EPS NY rev (1m)-0.02%
EPS NY rev (3m)-4.18%
Revenue NQ rev (1m)-0.1%
Revenue NQ rev (3m)-1.76%
Revenue NY rev (1m)-0.02%
Revenue NY rev (3m)-0.57%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 20.08 | ||
| Fwd PE | 17.86 | ||
| P/S | 1.96 | ||
| P/FCF | 32.25 | ||
| P/OCF | 20.65 | ||
| P/B | 2.82 | ||
| P/tB | N/A | ||
| EV/EBITDA | 15.99 |
EPS(TTM)2.85
EY4.98%
EPS(NY)3.2
Fwd EY5.6%
FCF(TTM)1.77
FCFY3.1%
OCF(TTM)2.77
OCFY4.84%
SpS29.17
BVpS20.29
TBVpS-13.7
PEG (NY)N/A
PEG (5Y)2.91
Graham Number36.07
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 4.95% | ||
| ROE | 13.49% | ||
| ROCE | 8.75% | ||
| ROIC | 6.25% | ||
| ROICexc | 6.42% | ||
| ROICexgc | 45.17% | ||
| OM | 11.59% | ||
| PM (TTM) | 9.38% | ||
| GM | 31.05% | ||
| FCFM | 6.08% |
ROA(3y)5.83%
ROA(5y)5.83%
ROE(3y)14.91%
ROE(5y)14.57%
ROIC(3y)7.83%
ROIC(5y)7.26%
ROICexc(3y)8.08%
ROICexc(5y)7.6%
ROICexgc(3y)56.9%
ROICexgc(5y)49.07%
ROCE(3y)10.54%
ROCE(5y)9.74%
ROICexgc growth 3Y30.99%
ROICexgc growth 5Y25.82%
ROICexc growth 3Y12.8%
ROICexc growth 5Y10.57%
OM growth 3Y2.71%
OM growth 5Y2.05%
PM growth 3Y-5.45%
PM growth 5Y-3.59%
GM growth 3Y-0.05%
GM growth 5Y-0.42%
F-Score5
Asset Turnover0.53
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.76 | ||
| Debt/FCF | 9.31 | ||
| Debt/EBITDA | 3.47 | ||
| Cap/Depr | 96.19% | ||
| Cap/Sales | 3.42% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 62.74% | ||
| Profit Quality | 64.85% | ||
| Current Ratio | 0.61 | ||
| Quick Ratio | 0.37 | ||
| Altman-Z | 2.28 |
F-Score5
WACC7.55%
ROIC/WACC0.83
Cap/Depr(3y)93.3%
Cap/Depr(5y)88.79%
Cap/Sales(3y)3.26%
Cap/Sales(5y)3.28%
Profit Quality(3y)86.51%
Profit Quality(5y)84.12%
High Growth Momentum
Growth
EPS 1Y (TTM)-21.7%
EPS 3Y6.45%
EPS 5Y6.91%
EPS Q2Q%-26.26%
EPS Next Y-14.35%
EPS Next 2Y-3.62%
EPS Next 3Y0.47%
EPS Next 5Y3.92%
Revenue 1Y (TTM)4.13%
Revenue growth 3Y8.26%
Revenue growth 5Y7.09%
Sales Q2Q%5.87%
Revenue Next Year4.85%
Revenue Next 2Y4.33%
Revenue Next 3Y4.1%
Revenue Next 5Y3.83%
EBIT growth 1Y-29.74%
EBIT growth 3Y11.2%
EBIT growth 5Y9.29%
EBIT Next Year6.67%
EBIT Next 3Y6.61%
EBIT Next 5Y7.99%
FCF growth 1Y-34.14%
FCF growth 3Y3.52%
FCF growth 5Y2.99%
OCF growth 1Y-21.27%
OCF growth 3Y5.84%
OCF growth 5Y4.37%
MONDELEZ INTERNATIONAL INC-A / MDLZ FAQ
Can you provide the ChartMill fundamental rating for MONDELEZ INTERNATIONAL INC-A?
ChartMill assigns a fundamental rating of 5 / 10 to MDLZ.
Can you provide the valuation status for MONDELEZ INTERNATIONAL INC-A?
ChartMill assigns a valuation rating of 3 / 10 to MONDELEZ INTERNATIONAL INC-A (MDLZ). This can be considered as Overvalued.
What is the profitability of MDLZ stock?
MONDELEZ INTERNATIONAL INC-A (MDLZ) has a profitability rating of 7 / 10.
Can you provide the PE and PB ratios for MDLZ stock?
The Price/Earnings (PE) ratio for MONDELEZ INTERNATIONAL INC-A (MDLZ) is 20.08 and the Price/Book (PB) ratio is 2.82.
Can you provide the dividend sustainability for MDLZ stock?
The dividend rating of MONDELEZ INTERNATIONAL INC-A (MDLZ) is 6 / 10 and the dividend payout ratio is 69.92%.